Results 101 to 110 of about 5,002 (185)

Supplementary Data from Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer

open access: yes, 2019
Supplementary Figures 1-5 further support our findings regarding the contribution to the maintenance of intracellular pH for ASS1 downregulated cancer ...
Sandesh C.S. Nagamani (14937437)   +21 more
core   +1 more source

[Therapeutic efficacy of ASS1 combined with LOLA in the treatment of hyperammonemia in mice]. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban
Argininosuccinate synthase 1 (ASS1) is a key rate-limiting enzyme in the urea cycle and is highly conserved at the protein level. Its catalytic activity directly determines the efficiency of ammonia clearance. Hyperammonemia is a clinical syndrome caused by abnormally elevated blood ammonia levels and is characterized mainly by central nervous system ...
Luo T, Ming Z, Zou Z, Luo Z.
europepmc   +3 more sources

ASS1 protein is expressed in mesothelioma samples and upregulated when compared to normal tissues.

open access: yes, 2016
(A) ASS1 stain intensity was measured in 88 mesothelioma samples by immunohistochemistry (each tumor in replicates of 3) in a semi-quantitative fashion as outlined in the Methods section.
Dario Barbone (111176)   +8 more
core   +1 more source

Additional file 2: of Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review

open access: yes, 2019
Table S2. Primers used for PCR and Sanger sequencing of exon 11 of ASS1.
Lin Zhu (192179)   +8 more
core   +1 more source

Abstract 4445: Pegylated arginine deiminase induces mitochondrial apoptosis and synergizes with cisplatin in ASS1-negative malignant pleural mesothelioma

open access: yes, 2010
We have explored the role of pegylated arginine deiminase (ADI-PEG20), an arginine catabolizing enzyme, in argininosuccinate synthetase 1 (ASS1)-negative malignant pleural mesothelioma (MPM). MPM is a chemorefractory disease, increasing worldwide, with a
Claude Chelala   +6 more
core   +1 more source

Invasive lobular carcinoma: integrated multi-omics analysis reveals silencing of Argininosuccinate synthase and upregulation of nucleotide biosynthesis in tamoxifen resistance

open access: yesCell Death and Disease
Invasive Lobular Carcinoma (ILC), a distinct subtype of breast cancer, is hallmarked by E-Cadherin loss, slow proliferation, and strong hormone receptor positivity.
Annapurna Gupta   +10 more
doaj   +1 more source

Figure-S4 from ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance

open access: yes, 2013
Figure-S4 PDF file 86K, Figure-S4 ASS1 reexpression induces cell cycle arrest at the G1 phase in myxofibrosarcoma cells with consistent downregulation of cyclin E expression.
Fu-Min Fang (502561)   +13 more
core   +1 more source

Case Report: From coma to genetic insights: identification of a novel pathogenic variant in Chinese neonatal CTLN1

open access: yesFrontiers in Pediatrics
Citrullinemia type I (CTLN1) is an autosomal recessive disorder caused by variants in the arginine succinate synthase gene (ASS1). These variants result in arginine succinate synthase deficiency, leading to a disruption of the urea cycle and ...
Lijing Deng   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy